TUBB3 and central nervous system cancer: Epothiolones have been shown to act on TUBB3-expressing glioma cells by inhibiting cell motility through cytoskeleton disruption, promoting tumor cell death by survivin down-regulation and by mediating therapeutic effects in preclinical models [28–30].